Analysis of the retail pharmaceutical market of analgesic drugs Meloxicam and Nalbuphine included in military first aid kits since the beginning of hostilities in Ukraine
DOI:
https://doi.org/10.24959/nphj.25.179Keywords:
pharmaceutical market; analgesic drug; “Meloxicam”; “Nalbuphine”; pharmaceutical supply; pharmacy; physical availability; military first aid kit.Abstract
Aim. To analyze the range and physical and socio-economic availability of analgesic drugs (ADs) based on the international nonproprietary names (INN) Meloxicam (M01AC06) and Nalbuphine (N02AF02), which have been or are currently included in military first aid kits since the beginning of hostilities in Ukraine.
Materials and methods. The study used data from the State Register of Medicinal Products of Ukraine and the online drug search and reservation service Tabletki.ua for May 2025. Methods of comparison, systematization, and statistical analysis of prices and availability in pharmacies in Ivano-Frankivsk were applied, using the Pearson’s correlation coefficient (PCC) and the interquartile range (IQR).
Results. Analgesic drugs with INN “Meloxicam” used in the form of tablets or ampoules in the individual military first aid kit (IMFAK) or other first-aid kits for military needs were represented by a wider range in the local retail market and were more affordable than INN “Nalbuphine”. Thus, according to the analysis, as of May 2025, the pharmaceutical market of Ivano-Frankivsk offered 29 trade names (TNs) of Meloxicam and 7 TNs of Nalbuphine. The PCC calculation showed no linear relationship between the price and the number of pharmacies offering the drugs studied, while the IQR coefficient indicated the market stability for both INNs. In general, drugs produced by Ukrainian manufacturers were found to be the most affordable.
Conclusions. The range of analgesic drugs based on Meloxicam is broader than that of Nalbuphine. The economic feasibility of using Meloxicam, along with its higher safety applications, has been confirmed by price stability and a greater number of the market offers in the pharmaceutical sector.
References
Sholoiko, N. V. (2017). Orhanizatsiia nadannia domedychnoi dopomohy v umovakh boiovykh dii. Ukrainskyi viiskovo-medychnyi almanakh, 3(55), 55–59.
Nadannia pershoi medychnoi dopomohy v umovakh boiovykh dii (v sektori obstrilu). (2017, Lystopad 18). https://navy.mil.gov.ua/ua/nadannia-pershoi-medychnoi-dopomohy-v-umovakh-boiovykh-dii-v-sektori-obstrilu
Chorna, V. V., Matviichuk, M. V., Podolian, V. M., Ivashkevych, Ye. M., Syvak, V. M., Slobodian, V. V., & Ivashkevych, M. S. (2022). Aktualni pytannia zabezpechennia indyvidualnymy medychnymy zasobamy zakhystu viiskovosluzhbovtsiv, tsyvilnykh Ukrainy. Ukrainskyi zhurnal viiskovoi medytsyny, 2(3), 92–99. http://doi.org/10.46847/ujmm.2022.2(3)-092
Yakymenko, O. V., Ivanchenko, V. I., & Lytvynenko, A. S. (2016). Vymohy do osnashchennia indyvidualnoi aptechky viiskovosluzhbovtsia v umovakh suchasnoho boiu. Ukrainskyi viiskovo-medychnyi almanakh, (2), 113–117.
Toblin, R. L., Quartana, P. J., Riviere, L. A., Walper, K. C., & Huertas, E. E. (2014). Chronic Pain and Opioid Use in US Soldiers After Combat Deployment. JAMA Internal Medicine, 174(8), 1400–1401. http://doi.org/10.1001/jamainternmed.2014.2726
Sanitarnyi minimum dlia osobovoho skladu Zbroinykh Syl Ukrainy. (2008). Viiskovo-medychne upravlinnia Ministerstva oborony Ukrainy.
Nakaz Ministerstva oborony Ukrainy «Pro zatverdzhennia pereliku osnashchennia indyvidualnoi aptechky viiskovosluzhbovtsia» № 1087 (2014, Serpen 19). https://zakon.rada.gov.ua/rada/show/v1087848-14#Text
Nakaz Ministerstva oborony Ukrainy «Pro zatverdzhennia Perelikiv likarskykh zasobiv ta medychnykh vyrobiv, yakymy zabezpechuietsia osobovyi sklad syl bezpeky i syl oborony dlia nadannia taktychnoi dohospitalnoi dopomohy» № 506 (2024, Lypen 24). https://zakon.rada.gov.ua/laws/show/z1171-24#Text
Committee on Tactical Combat Casualty Care (CoTCCC). Joint Trauma System. https://jts.health.mil/index.cfm/committees/cotccc
Nalbufin. Instruktsiia dlia medychnoho zastosuvannia likarskoho zasobu. Derzhavnyi reiestr likarskykh zasobiv Ukrainy, reiestratsiine posvidchennia UA/14429/01/01. https://likicontrol.com.ua/%D1%96%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D1%96%D1%8F/?[12473]
Meloksykam. Instruktsiia dlia medychnoho zastosuvannia likarskoho zasobu. Derzhavnyi reiestr likarskykh zasobiv Ukrainy, reiestratsiine posvidchennia UA/7390/02/02. https://likicontrol.com.ua/%D1%96%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D1%96%D1%8F/?%5B5671%5D
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. http://www.drlz.com.ua/
Tabletki.ua – poshuk ta broniuvannia likiv v aptekakh. https://tabletki.ua/
NTU Ukrainy «KPI imeni I. Sikorskoho». (2023). Statystychni metody vyznachennia zalezhnostei mizh vypadkovymy velychynamy: navch. posib.
Chornomorskyi natsionalnyi universytet imeni P. Mohyly. (2022). Koefitsiient koreliatsii Pirsona (r-Pirsona): metod. rek.
Shevchenko, I. P. (2016). Statystyka dlia doslidnykiv: metod. posib. Naukova dumka.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
